Mindpeak
Germany - HamburgBiotechnology
Focus: Mindpeak is an AI-powered pathology platform specializing in cancer biomarker detection and diagnostic image recognition for oncology. The company operates as a publicly-traded biotech firm founded in 2018, headquartered in Hamburg, Germany.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
8-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Mindpeak?
AI assessmentBest suited for technologists or medical professionals seeking early-stage AI oncology exposure in a growth-stage, publicly-traded setting with meaningful commercial partnerships already forming.
Why Work Here
- Positioned at the intersection of AI and precision oncology diagnostics, with recent partnerships (Discovery Life Sciences, Epredia) validating market traction
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Mindpeak
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.